Original Research
Accepted on 14 May 2026
Anti-CGRP Monoclonal Antibody therapy for Migraine is not associated with early adverse bone effects: A prospective, observational, controlled, cohort study
in Headache and Neurogenic Pain
- 581 views
Original Research
Accepted on 14 May 2026
in Headache and Neurogenic Pain
Original Research
Accepted on 14 May 2026
in Neurotrauma
Brief Research Report
Accepted on 14 May 2026
in Cognitive Neuroscience
Original Research
Accepted on 14 May 2026
in Cognitive Neuroscience
Perspective
Published on 14 May 2026
in Intensive Care Medicine and Anesthesiology
Original Research
Published on 14 May 2026
in Breast Cancer
Brief Research Report
Published on 14 May 2026
in Digital Public Health
Systematic Review
Published on 14 May 2026
in Aging and Public Health
Original Research
Published on 14 May 2026
in Psychology in Education
Original Research
Published on 14 May 2026
in Microbiological Chemistry and Geomicrobiology
Original Research
Published on 14 May 2026
in Clinical Nutrition
Original Research
Published on 14 May 2026
in Infectious Diseases: Epidemiology and Prevention
Original Research
Published on 14 May 2026
in Molecular Psychiatry
Original Research
Published on 14 May 2026
in Lipid and Fatty Acid Research
Original Research
Published on 14 May 2026
in Public Health Policy
Perspective
Published on 14 May 2026
in Psychology for Clinical Settings